|
|||||
|
|
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial |
|
| Authors: | Masuda Norikazu Bando Hiroko Yamanaka Takashi Kadoya Takayuki Takahashi Masato Nagai Shigenori E. Ohtani Shoichiro Aruga Tomoyuki Suzuki Eiji Kikawa Yuichiro Yasojima Hiroyuki Kasai Hiroi Ishiguro Hiroshi Kawabata Hidetaka Morita Satoshi Haga Hironori Kataoka Tatsuki R. Uozumi Ryuji Ohno Shinji Toi Masakazu |
| Affiliation: | 1.Department of Surgery, Breast Oncology, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuou-ku, Osaka, Japan ;2.Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan ;3.Breast and Endocrine Surgery, Kanagawa Cancer Center, Kanagawa, Japan ;4.Department of Breast Surgery, Hiroshima University Hospital, Hiroshima University, Hiroshima, Japan ;5.Department of Breast Surgery, NHO Hokkaido Cancer Center, Hokkaido, Japan ;6.Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan ;7.Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan ;8.Breast Surgery Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan ;9.Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan ;10.Department of Breast Surgery, Kobe City Medical Center General Hospital, Hyogo, Japan ;11.Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan ;12.Breast Oncology Service, Saitama Medical University International Medical Center, Saitama, Japan ;13.Department of Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan ;14.Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan ;15.Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan ;16.Breast Oncology Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan ; |
| Abstract: | Breast Cancer Research and Treatment - To investigate clinical usefulness of eribulin-based neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) patients. Patients in group A... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |